🔆 Beacon

← Search all trials on Beacon

Safety and Tolerability of Open-Labeled Iloperidone in Adolescents

Recruiting now Phase 4 NCT05648591

Run by Vanda Pharmaceuticals · for 12 to 17 · All sexes

What this study is about

To evaluate the safety and tolerability of iloperidone in adolescent patients with schizophrenia or bipolar I disorder for up to 52 weeks of treatment.

Who can join (things the study team will check)

✅ You may be able to join if…

🚫 You may not be able to join if…

Where this trial is running

Who to contact

Vanda Pharmaceuticals Inc. · 202-734-3400 · clinicaltrials@vandapharma.com

It's completely normal to call and ask questions before deciding anything. Mention the study ID: NCT05648591.

Open the interactive checklist for this trial →

Verify everything on the official ClinicalTrials.gov record. Page updated July 2026.

Beacon is an information tool, not medical advice. Whether a trial is right for you is a decision for you, your doctor, and the study team. Trial details come from the official registry, ClinicalTrials.gov, and may change — always confirm with the study team. Beacon collects no data about you: this page has no cookies, no accounts, and no tracking.